These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocality. Shin DY, Kim KJ, Chang S, Kim H, Hwang S, Kim W, Bae J, Park S, Kang SW, Chung WY, Lee EJ. Head Neck; 2015 Nov; 37(11):1590-5. PubMed ID: 24909403 [Abstract] [Full Text] [Related]
8. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma]. Shi CL, Guo Y, Lyu YC, Nanding ZABYS, Gao WC, Shi TF, Qin HD, Liu SY. Zhonghua Zhong Liu Za Zhi; 2017 May 23; 39(5):361-366. PubMed ID: 28535653 [Abstract] [Full Text] [Related]
11. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydın O, Altiok E, Giray S, Azizlerli H. Endocrine; 2012 Oct 23; 42(2):404-10. PubMed ID: 22426956 [Abstract] [Full Text] [Related]
12. BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo do H, Youn YK. World J Surg; 2012 Feb 23; 36(2):310-7. PubMed ID: 22190222 [Abstract] [Full Text] [Related]
13. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation]. Yang X, Liang ZY, Meng C, Liang J, Yu Z, Lin YS. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug 23; 35(4):398-403. PubMed ID: 23987486 [Abstract] [Full Text] [Related]
15. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse. Renaud F, Gnemmi V, Devos P, Aubert S, Crépin M, Coppin L, Ramdane N, Bouchindhomme B, d'Herbomez M, Van Seuningen I, Do Cao C, Pattou F, Carnaille B, Pigny P, Wémeau JL, Leteurtre E. Thyroid; 2014 Sep 23; 24(9):1375-84. PubMed ID: 25012490 [Abstract] [Full Text] [Related]
16. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Kwak JY, Kim EK, Chung WY, Moon HJ, Kim MJ, Choi JR. Radiology; 2009 Dec 23; 253(3):854-60. PubMed ID: 19710001 [Abstract] [Full Text] [Related]
17. Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis. Bernstein J, Virk RK, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman SA, Sosa JA, Prasad ML. Thyroid; 2013 Dec 23; 23(12):1525-31. PubMed ID: 23682579 [Abstract] [Full Text] [Related]
18. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression. Kim MH, Bae JS, Lim DJ, Lee H, Jeon SR, Park GS, Jung CK. Endocr Relat Cancer; 2014 Dec 23; 21(6):891-902. PubMed ID: 25266729 [Abstract] [Full Text] [Related]
19. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS. Endocr Relat Cancer; 2016 Jan 23; 23(1):27-34. PubMed ID: 26598713 [Abstract] [Full Text] [Related]